The going has gotten tough in the orthopedic sector, and many of the major players have responded by getting going. Johnson & Johnson (NYSE: JNJ ) acquired Synthes to become the largest in trauma and the second-largest in spine, while Stryker (NYSE: SYK ) acquired MAKO Surgical with an eye toward getting ahead of the evolution of the hip and knee markets. Smith & Nephew
has diversified into wound care and arthroscopy, while Biomet is
reportedly weighing its options, including a possible IPO. That leaves Zimmer Holdings (NYSE: ZMH ) as the next major player to move.
Zimmer has already done what many of its rivals have found hard to do
-- deliver real growth in a tough major joint recon market. Zimmer's
knee sales were up 7% in the latest quarter, while hips were up 2%, and
recent introductions like the Persona line have helped extend the
company's lead in major joint reconstruction, with more than one-quarter
market share (Johnson & Johnson is a few points behind, and Stryker
is even further back). With a relatively clean balance sheet and some
obvious areas to improve, though, Zimmer could have a trick up its
sleeve to invigorate growth.
Continue reading here:
http://www.fool.com/investing/general/2013/12/18/a-sleeping-giant-about-to-awaken.aspx?source=itxsitmot0000001&lidx=1
No comments:
Post a Comment